Zynerba Pharmaceuticals Buy Hold or Sell Recommendation
| ZYNEDelisted Stock | USD 0.36 0.01 2.70% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Zynerba Pharmaceuticals is 'Not Rated'. Macroaxis provides Zynerba Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ZYNE positions.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Note, we conduct extensive research on individual companies such as Zynerba and provide practical buy, sell, or hold advice based on investors' constraints. Zynerba Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Zynerba |
Execute Zynerba Pharmaceuticals Buy or Sell Advice
The Zynerba recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Zynerba Pharmaceuticals. Macroaxis does not own or have any residual interests in Zynerba Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Zynerba Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Zynerba Pharmaceuticals Trading Alerts and Improvement Suggestions
| Zynerba Pharmaceuticals is not yet fully synchronised with the market data | |
| Zynerba Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Zynerba Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (35.04 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Zynerba Pharmaceuticals currently holds about 62.49 M in cash with (23.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Zynerba Pharmaceuticals Returns Distribution Density
The distribution of Zynerba Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Zynerba Pharmaceuticals' future price movements. The chart of the probability distribution of Zynerba Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Zynerba Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Zynerba Pharmaceuticals returns is essential to provide solid investment advice for Zynerba Pharmaceuticals.
| Mean Return | -0.07 | Value At Risk | -6.25 | Potential Upside | 6.45 | Standard Deviation | 4.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Zynerba Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition pursuant to a tender of shares in a change of control transaction by Kenneth Moch of Zynerba Pharmaceuticals [view details]
Zynerba Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Zynerba . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Zynerba Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Zynerba Pharmaceuticals? Buying financial instruments such as Zynerba Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Zynerba Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |